Goal: Expand NIDA’s existing Clinical Trials Network to reach more communities in areas of the country hard hit by the opioids crisis.
The National Drug Abuse Treatment Clinical Trials Network (CTN) facilitates collaboration between NIDA, research scientists at universities, and treatment providers in the community with the aim of developing, testing, and implementing new addiction treatments. The network has contributed to broad reaching changes in medical practice, including the development of the opioid treatment medication buprenorphine. The CTN Opioid Research Enhancement Project will greatly expand the CTN’s capacity to conduct trials by adding new sites and new investigators. The funds will enable the expansion of existing studies and facilitate developing and implementing new studies to improve access to high-quality addiction treatment, for example, by facilitating delivery of opioid use disorder treatment in general medical settings. It will also create new opportunities for clinical and research training.
NIDA Contact: Dr. Ron Dobbins
Projects Started to Date
- 9/13/2018: Analyses of VA Databases to Examine Patient Characteristics Associated with Buprenorphine Termination During Opioid Use Disorder Treatment
- 9/13/2018: Medicaid Analysis of Oregon and Oklahoma Data Comparing Outcomes in Residential and Outpatient Treatment
- 9/12/2018: Selection Bias Free Estimation of the Impact of Drug-focused Twelve Step Mutual Help Groups Using the VA Database
- 8/23/2018: Developing a Prescription Opioid Registry in Diverse Health Care Delivery Systems Based on Retrospective Prescription Opioid Registry Experience
Emerging Trends & Alerts
Get more information on Emerging Trends and Alerts, we will update this page with the latest research findings as they develop.
Get this Publication
Find information about addiction and mental health services in your area. You can search by state or zip code online or call the number. (SAMHSA)